Kassi Fulgence K, Bellet Virginie, Doumbia Adama, Krasteva Donika, Drakulovski Pascal, Kouakou Gisèle A, Gatchitch François, Delaporte Eric, Reynes Jacques, Mallié Michèle, Menan Hervé I E, Bertout Sébastien
Université Félix Houphouët Boigny, UFR Pharmacie, Laboratoire de Parasitologie et Mycologie - CeDReS (Centre de Diagnostic et de Recherche sur le SIDA et les autres maladies infectieuses), CHU de Treichville, BP V3, Abidjan, Cote d'Ivoire; UMI 233 IRD-UM-INSERM U1175 Laboratoire de Parasitologie et Mycologie médicale UFR Pharmacie, 15 Av. C. Flahault, BP 14491, 34093 Montpellier Cedex 5, France.
UMI 233 IRD-UM-INSERM U1175 Laboratoire de Parasitologie et Mycologie médicale UFR Pharmacie , 15 Av. C. Flahault, BP 14491, 34093 Montpellier Cedex 5 , France.
JMM Case Rep. 2016 Aug 30;3(4):e005037. doi: 10.1099/jmmcr.0.005037. eCollection 2016 Aug.
Cryptococcal meningitis (CM) may be caused by several species of
We describe a fatal case of CM in a HIV-positive patient from Ivory Coast infected by VNI and . Isolates were recovered from cerebrospinal fluid (CSF) prior to systemic antifungal treatment. Six isolates were studied (the entire culture plus five isolated colonies from it). Serotyping was performed via LAC 1 and CAP 64 gene amplification. Genotyping was performed using restriction fragment length polymorphism (RFLP) analysis of the URA5 gene, (GACA), (GTG) and M13 PCR fingerprinting. URA5-RFLP analysis identified the original culture with two different molecular type combinations. However, URA5-RFLP profiles of the five colonies isolated from the original sample revealed two different species. Four colonies were identified as and the last isolate as VNI. The susceptibility profile was determined using the standard method according to the CLSI M27-A3 protocol. The isolates were susceptible to the tested antifungals (fluconazole, flucytosine and amphotericin B). Treatment with fluconazole (1200 mg day) was initiated; however, the patient died 17 days after the onset of antifungal therapy.
This is the first reported case of mixed infection with and in a HIV-positive patient.
隐球菌性脑膜炎(CM)可能由多种隐球菌引起。
我们描述了一名来自科特迪瓦的HIV阳性患者发生的致命性CM病例,该患者感染了VNI和[此处原文缺失信息]。在进行全身抗真菌治疗之前,从脑脊液(CSF)中分离出了菌株。对六个菌株进行了研究(整个培养物加上从中分离出的五个菌落)。通过LAC 1和CAP 64基因扩增进行血清分型。使用URA5基因的限制性片段长度多态性(RFLP)分析、(GACA)、(GTG)和M13 PCR指纹图谱进行基因分型。URA5-RFLP分析确定原始培养物具有两种不同的分子类型组合。然而,从原始样本中分离出的五个菌落的URA5-RFLP图谱显示出两种不同的物种。四个菌落被鉴定为[此处原文缺失信息],最后一个分离株被鉴定为VNI。根据CLSI M27-A3协议的标准方法确定了[此处原文缺失信息]的药敏谱。分离株对所测试的抗真菌药物(氟康唑、氟胞嘧啶和两性霉素B)敏感。开始使用氟康唑(1200毫克/天)进行治疗;然而,患者在抗真菌治疗开始后17天死亡。
这是首次报道的HIV阳性患者中[此处原文缺失信息]和VNI混合感染的病例。